ELMD icon

Electromed

24.42 USD
+0.03
0.12%
At close Updated Sep 17, 10:03 AM EDT
1 day
0.12%
5 days
2.56%
1 month
24.02%
3 months
21.67%
6 months
-1.45%
Year to date
-18.87%
1 year
22.59%
5 years
134.58%
10 years
1,198.94%
 

About: Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

Employees: 180

0
Funds holding %
of 7,463 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

78% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 18

2.59% more ownership

Funds ownership: 43.35% [Q1] → 45.94% (+2.59%) [Q2]

4% less capital invested

Capital invested by funds: $88.5M [Q1] → $84.7M (-$3.72M) [Q2]

12% less funds holding

Funds holding: 94 [Q1] → 83 (-11) [Q2]

35% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 31

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$35
43% upside
Avg. target
$36
45% upside
High target
$36
47% upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
Roth Capital
Kyle Bauser
$35
Buy
Maintained
27 Aug 2025
Lake Street
Benjamin Haynor
$36
Buy
Assumed
27 Aug 2025

Financial journalist opinion

Based on 8 articles about ELMD published over the past 30 days

Positive
Zacks Investment Research
yesterday
Electromed (ELMD) is an Incredible Growth Stock: 3 Reasons Why
Electromed (ELMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Electromed (ELMD) is an Incredible Growth Stock: 3 Reasons Why
Positive
Zacks Investment Research
yesterday
Wall Street Analysts Believe Electromed (ELMD) Could Rally 52.14%: Here's is How to Trade
The mean of analysts' price targets for Electromed (ELMD) points to a 52.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Believe Electromed (ELMD) Could Rally 52.14%: Here's is How to Trade
Neutral
Business Wire
8 days ago
Electromed, Inc. Announces Share Repurchase Authorization
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Share Repurchase Authorization.
Electromed, Inc. Announces Share Repurchase Authorization
Positive
Zacks Investment Research
19 days ago
3 Reasons Growth Investors Will Love Electromed (ELMD)
Electromed (ELMD) could produce exceptional returns because of its solid growth attributes.
3 Reasons Growth Investors Will Love Electromed (ELMD)
Positive
Zacks Investment Research
19 days ago
Electromed (ELMD) Upgraded to Buy: Here's What You Should Know
Electromed (ELMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Electromed (ELMD) Upgraded to Buy: Here's What You Should Know
Positive
Zacks Investment Research
19 days ago
Does Electromed (ELMD) Have the Potential to Rally 38.6% as Wall Street Analysts Expect?
The mean of analysts' price targets for Electromed (ELMD) points to a 38.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Does Electromed (ELMD) Have the Potential to Rally 38.6% as Wall Street Analysts Expect?
Neutral
Seeking Alpha
21 days ago
Electromed, Inc. (ELMD) Q4 2025 Earnings Call Transcript
Electromed, Inc. (NYSE:ELMD ) Q4 2025 Earnings Conference Call August 26, 2025 5:00 PM ET Company Participants Bradley M. Nagel - CFO, Treasurer & Secretary James L.
Electromed, Inc. (ELMD) Q4 2025 Earnings Call Transcript
Neutral
Business Wire
21 days ago
Electromed, Inc. Announces Record Fiscal 2025 Fourth Quarter and Full Year Financial Results
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ("Q4 FY 2025") and full year ended June 30, 2025 ("FY 2025"). Q4 FY 2025 Company Highlights Net revenue increased 17.3% to a record $17.4 million in Q4 FY 2025, from $14.8 million in the fourth quarter of the prior fiscal year. Operating income was a record $3.0 million, a 30.2% increase from the f.
Electromed, Inc. Announces Record Fiscal 2025 Fourth Quarter and Full Year Financial Results
Neutral
Business Wire
1 month ago
Electromed, Inc. to Report Q4 Fiscal 2025 Financial Results on August 26, 2025
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2025 fourth quarter ended June 30, 2025, on August 26, 2025 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the ca.
Electromed, Inc. to Report Q4 Fiscal 2025 Financial Results on August 26, 2025
Neutral
Business Wire
1 month ago
Electromed, Inc. to Participate in the Canaccord Genuity 45th Annual Growth Conference
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed to Participate in Canaccord Genuity 45th Annual Growth Conference.
Electromed, Inc. to Participate in the Canaccord Genuity 45th Annual Growth Conference
Charts implemented using Lightweight Charts™